Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a3810dccdb99eec7b3514fd419e1dd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c62e91cb840efd91abdfa4caf3e4597 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_941de20c752904deb44e1c16dc29b0eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
filingDate |
2004-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043545a78b181fcb9f1631bfd388753c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ea4304f1d7f0ac730903fc42809cb3 |
publicationDate |
2004-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004069228-A2 |
titleOfInvention |
Sustained release formulations of venlafaxine |
abstract |
The present invention relates to sustained release tablet formulations of venlafaxine. Kollidon SR proved to be an excellent sustained release agent for venlafaxine, that is an extremely soluble drug. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005074895-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-010825-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005053657-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005053657-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007102169-A1 |
priorityDate |
2003-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |